Literature DB >> 19558793

Enzymatic properties of the N- and C-terminal halves of human hexokinase II.

Keun Jae Ahn1, Jongsun Kim, Mijin Yun, Jeon Han Park, Jong Doo Lee.   

Abstract

Although previous studies on hexokinase (HK) II indicate both the N- and C-terminal halves are catalytically active, we show in this study the N-terminal half is significantly more catalytic than the C-terminal half in addition to having a significantly higher Km for ATP and Glu. Furthermore, truncated forms of intact HK II lacking its first N-terminal 18 amino acids (delta18) and a truncated N-terminal half lacking its first 18 amino acids (delta18N) have higher catalytic activity than other mutants tested. Similar results were obtained by PET-scan analysis using (18)FFDG. Our results collectively suggest that each domain of HK II possesses enzyme activity, unlike HK I, with the N-terminal half showing higher enzyme activity than the C-terminal half.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558793     DOI: 10.5483/bmbrep.2009.42.6.350

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  17 in total

1.  Expression and role in glycolysis of human ADP-dependent glucokinase.

Authors:  Susan Richter; Jan P Richter; Sunali Y Mehta; Amanda M Gribble; Andrew J Sutherland-Smith; Kathryn M Stowell; Cristin G Print; Ron S Ronimus; William R Wilson
Journal:  Mol Cell Biochem       Date:  2012-01-05       Impact factor: 3.396

2.  Molecular and biochemical characterization of Eimeria tenella hexokinase.

Authors:  Mingfei Sun; Shenquan Liao; Longxian Zhang; Caiyan Wu; Nanshan Qi; Minna Lv; Juan Li; Xuhui Lin; Jianfei Zhang; Mingquan Xie; Guan Zhu; Jianping Cai
Journal:  Parasitol Res       Date:  2016-05-06       Impact factor: 2.289

3.  Association of HK2 and NCK2 with normal-tension glaucoma in a population from the Republic of Korea.

Authors:  Seung-Hyun Jung; Young Chun Lee; Mee Yon Lee; Hye-Young Shin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-11       Impact factor: 3.117

Review 4.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

5.  A unique hexokinase in Cryptosporidium parvum, an apicomplexan pathogen lacking the Krebs cycle and oxidative phosphorylation.

Authors:  Yonglan Yu; Haili Zhang; Fengguang Guo; Mingfei Sun; Guan Zhu
Journal:  Protist       Date:  2014-08-20

6.  Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes.

Authors:  David J Roberts; Valerie P Tan-Sah; Jeffery M Smith; Shigeki Miyamoto
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

7.  Targeting hexokinase 2 in castration-resistant prostate cancer.

Authors:  Yibin Deng; Junxuan Lu
Journal:  Mol Cell Oncol       Date:  2015-04-30

Review 8.  Liver glucose metabolism in humans.

Authors:  María M Adeva-Andany; Noemi Pérez-Felpete; Carlos Fernández-Fernández; Cristóbal Donapetry-García; Cristina Pazos-García
Journal:  Biosci Rep       Date:  2016-11-29       Impact factor: 3.840

Review 9.  Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis.

Authors:  Italo Mario Cesari; Erika Carvalho; Mariana Figueiredo Rodrigues; Bruna Dos Santos Mendonça; Nivea Dias Amôedo; Franklin David Rumjanek
Journal:  Int J Cell Biol       Date:  2014-02-06

Review 10.  Chaperone-mediated autophagy substrate proteins in cancer.

Authors:  Ying Tang; Xiong-Wen Wang; Zhan-Hua Liu; Yun-Ming Sun; Yu-Xin Tang; Dai-Han Zhou
Journal:  Oncotarget       Date:  2017-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.